DOCSLIB.ORG

2021 BREAST ULTRASOUND with TOM STAVROS Hot Topics in Advanced Screening and Diagnosis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2021 BREAST ULTRASOUND with TOM STAVROS Hot Topics in Advanced Screening and Diagnosis 21 CMEs 5 SAMs 2021 BREAST ULTRASOUND WITH TOM STAVROS Hot Topics in Advanced Screening and Diagnosis JANUARY 15-17, 2021 THE WESTIN RIVERWALK SAN ANTONIO, TX WorldClassCME.com (888) 207-9105 PROGRAM DIRECTOR: Michael J. Ulissey, MD, FACR FACULTY: A. Thomas Stavros, MD, FACR, FSRU, FRANZCR; Susan G. Roux, MD; Lori Strachowski, MD, FSRU; Michael J. Ulissey, MD, FACR; Allison H. Zupon, MD 21 AMA PRA Category 1 Credits™ These credits can be used toward ABR MOC Part 2 requirements 5 SAMs Credits These credits can be used toward ABR MOC Part 2 SA-CME requirements © 2020 World Class CME. ALL RIGHTS RESERVED “Welcome to San Antonio and Hot Topics in Advanced Screening and Diagnosis. This course will emphasize FACULTYFACULTY a new classification system on breast cancer and will focus on “non”-mass ultrasound findings, an analysis of causes of false negative BI-RADS 3 classifications, PROGRAM DIRECTOR and new ways of classifying breast nodules that can help objectively assign BI-RADS 4 subcategories and Michael J. Ulissey, MD, FACR improve ultrasound’s ability to serve as a biomarker. Adjunct Professor I will lead interactive case readings with an audience Department of Radiology response system, and we have time set aside for University of Texas Health Sciences Center questions and answers” San Antonio, Texas – Tom Stavros FACULTY A. Thomas Stavros, MD, FACR, FSRU, Lori Strachowski, MD, FSRU FRANZCR Clinical Professor of Radiology Professor Specialist University of California Department of Radiology San Francisco, California University of Texas Health Sciences Center San Antonio, Texas Michael J. Ulissey, MD, FACR Author: Breast Ultrasound Adjunct Professor Department of Radiology Susan G. Roux, MD University of Texas Health Sciences Center Medical Director San Antonio, Texas Carol Hatten Breast Care Center Community Hospital of the Monterey Peninsula Allison H. Zupon, MD Monterey, California Imaging for Women, LLC Kansas City, MO COURSE OBJECTIVES Upon completion of this conference, the participant will be able to: • Understand the differences in pre-test probabilities • Recognize the range of normal and abnormal appearances and guidelines for interpretation between diagnostic, for breast implants supplemental screening, and MRI-directed indications for • Enhance ultrasound-guided breast biopsy and interven- breast ultrasound and how that affects management and tional skills interpretation • Utilize the new classification system of breast • Select the most appropriate ultrasound equipment, malignancies that is based upon site of origin – within machine settings, and scan techniques for better ducts, within TDLUs, or within peri-ductal mesenchymal diagnostic evaluations tissues for better correlation with prognosis • Understand the anatomic and histopathologic basis for • Understand the appropriate role for supplemental ultrasound appearances bilateral whole breast ultrasound as well as other ancillary • Correlate areas of clinical, mammographic, screening imaging modalities in women with negative but dense ultrasound, or MRI concern with ultrasound, and mammograms understand the anatomic and histopathologic basis for • Improve detection and correct classification of small ultrasound appearances invasive breast cancers while minimizing false positive • Identify both mass and non-mass sonographic findings ultrasound examinations that are suspicious for malignancy, how to use them in • Learn how to overcome the headwinds in establishing a classifying breast masses and in staging breast cancers supplemental whole breast ultrasound program in women • Understand a new way of classifying ultrasound features with dense breasts that can aid in more objectively using and achieving • Learn to distinguish normal from abnormal regional ACR PPV benchmarks for BI-RADS 4 subcategories lymph nodes, determine whether abnormal nodes are and function better as biomarkers than prior methods of more likely metastatic or reactive, and how Z0011 might classification affect current management of nodes • Identify the few truly suspicious complex cystic and solid • Become familiar with a new functional imaging platform masses that require biopsy and distinguish them from called Opto-acoustic Imaging the myriad of non-simple breast cysts that are definitively • Understand the benefits of integrating this new technology benign into breast ultrasound, so that the radiologist can • Understand the roles of ultrasound and galactography in significantly increase specificity when analyzing a mass, diagnosis and guiding biopsy in patients presenting with and potentially obviate the need for many breast biopsies nipple discharge REGISTRATION 2021 Breast Ultrasound with Tom Stavros Hot Topics in Advanced Screening and Diagnosis January 15-17, 2021 | The Westin Riverwalk | San Antonio, TX You may also register online at WorldClassCME.com or by phone at (888) 207-9105, M-F, 8:30 am - 5 pm EST Name (please print) Facility/Organization Degree Specialty Medical License# State ARRT# ARDMS# Military ID# Address City State Zip Phone E-mail Address (for confirmation and CME certificate) Registration Fees Group Registration Discount Sign up with others and get a Physician ....................................................................................$1,095 group discount! Call our office to Resident/Retired/Military/VA Physician* ..........................................$995 receive $75 off each registrant’s fee when you register two or more Advanced Practitioner (NP, PA) ......................................................$995 at the same time. Sonographer ..................................................................................$895 Refunds Single-Day Tuition .................Physician/NP/PA $795; Sonographer $695 A fee of $75 is charged for *Written certification of status required. cancellations received prior to the Payment Method (please make check payable to World Class CME) course date. Refunds cannot be issued after December 30, 2020. Check one: Discover Visa Master Card AMEX Name of Credit Card Holder Billing Address for Credit Card Account # Expiration Date CVC I Have ADA Needs Signature Please mail this form to: World Class CME, 6201 Fairview Rd Suite 200, Charlotte, NC 28210 Accreditation – World Class CME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. World Class CME designates this live activity for a maximum of 21 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The American Board of Radiology Maintenance of Certification – 21 AMA PRA Category 1 Credits™ – AMA credits can be used toward ABR MOC Part 2 requirements. SAM credits can be used toward ABR MOC Part 2 SA-CME requirements. Physician Assistants (PA) – The American Academy of Physician Assistants (AAPA) accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. This course qualifies for Category 1 CME for PAs. Nurse Practitioners and RNs – The American Nurses Credentialing Center and the American Academy of Nurse Practitioners Certification Program accept continuing education credits sponsored by organizations, agencies, or educational institutions accredited or approved by the Accreditation Council for Continuing Medical Education (ACCME). Category A CE credit is pending approval by the American Society of Radiologic Technologists. The American Registry of Diagnostic Medical Sonographers (ARDMS) accepts all American Society of Radiologic Technologists (ASRT) Category A credits as fulfilling their requirements for continuing education (CE) credits. This product (service) is not affiliated with or endorsed by Interleos, Inc™. ARDMS® and APCA™ are part of the Interleos™ family of certification councils. Disclosure – World Class CME relies on its CME faculty to provide program content that is evidence based and free of commercial bias. Therefore, in accordance with ACCME standards, any faculty, program director, reviewer, and/or provider industry relationships will be disclosed and resolved. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations. For disclaimers and other details about this course, visit WorldClassCME.com. PROGRAM FRIDAY, JANUARY 15, 2021 Time Program Faculty 7:00 Registration and Breakfast 7:25 Morning Announcements Ulissey 7:30 Breast Ultrasound Physics and Equipment Choices Stavros 8:00 Breast Ultrasound Anatomy – The Basis for Understanding Breast Stavros Pathology (SAM) 8:45 Breast Ultrasound Indications and Clinical and Mammographic Correlation Stavros with Ultrasound (1 SAM with above) 9:15 Questions and Answers Faculty 9:30 Break and Visit Exhibits 10:00 Ultrasound of Breast Cysts that Are Not Simple (SAM) Stavros 11:00 Ultrasound of Solid Breast Masses – How to Find the Border Between Stavros BI-RADS 3 and BI-RADS 4A 11:45 Questions and Answers Faculty 12:00 Lunch on Your Own 1:00 BI-RADS for Breast Ultrasound: What and How to Report (SAM) Strachowski 1:45 Evaluation of the Palpable Breast Mass in Females (1 SAM with above) Strachowski 2:15 Imaging the Male Breast Strachowski 2:45 Questions and Answer Faculty 2:55 Break and Visit Exhibits 3:20 Instructive Multi-modality Breast Cases Strachowski 4:00 Ultrasound Guided Breast Interventional Procedures Ulissey 4:30 An Introduction to Opto-acoustic Imaging Ulissey 5:00 Questions and Answers
Load more

Recommended publications
  • Evicore Breast Imaging Guidelines
    CLINICAL GUIDELINES Breast Imaging Guidelines Version 2.0 Effective September 1, 2021 eviCore healthcare Clinical Decision Support Tool Diagnostic Strategies: This tool addresses common symptoms and symptom complexes. Imaging requests for individuals with atypical symptoms or clinical presentations that are not specifically addressed will require physician review. Consultation with the referring physician, specialist and/or individual’s Primary Care Physician (PCP) may provide additional insight. CPT® (Current Procedural Terminology) is a registered trademark of the American Medical Association (AMA). CPT® five digit codes, nomenclature and other data are copyright 2017 American Medical Association. All Rights Reserved. No fee schedules, basic units, relative values or related listings are included in the CPT® book. AMA does not directly or indirectly practice medicine or dispense medical services. AMA assumes no liability for the data contained herein or not contained herein. © 2021 eviCore healthcare. All rights reserved. Breast Imaging Guidelines V2.0 Breast Imaging Guidelines Abbreviations for Breast Guidelines 3 BR-Preface1: General Considerations 5 BR-1: Breast Ultrasound 8 BR-2: MRI Breast 10 BR-3: Breast Reconstruction 12 BR-4: MRI Breast is NOT Indicated 13 BR-5: MRI Breast Indications 14 BR-6: Nipple Discharge/Galactorrhea 18 BR-7: Breast Pain (Mastodynia) 19 BR-8: Alternative Breast Imaging Approaches 20 BR-9: Suspected Breast Cancer in Males 22 BR-10: Breast Evaluation in Pregnant or Lactating Females 23 ______________________________________________________________________________________________________
    [Show full text]
  • Biopsy Needles and Drainage Catheters
    Needles & Accessories | Catheters & Accessories Dilation & Accessories Spinal & Accessories | Implantable & Accessories Product Catalog ISO 13485 & ISO 9001 Certified Company Rev. 01 - 2019/03 About ADRIA Srl. Adria is a worldwide leader in developing, manufacturing and marketing healthcare products. The main focus is on Radiology, Oncology, Urology, Gynecology and Surgery . Adria' s corporate headquarter is based in Italy, it is ISO Certified and products are CE . marked. Adria was incorporated more than 20 years ago in Bologna , where the corporate headquarter and production plant is located. Adria is leader in developing and manufacturing healthcare products and keeps the status to be one of the first companies aimed to develop single patient use biopsy needles and drainage catheters. Over the time, thanks to the experience of specialized doctors and engineers , Adria product range and quality have been progressively enhanced, involving and developing the spine treatment line. Nowadays Adria has a worldwide presence . Reference markets are France, Spain, Turkey and products are distributed in more than 50 countries, through a large and qualified network of dealers. Since far off the very beginning, many things have changed, but Adria' s philosophy and purpose have always remained unchanged: helping healthcare providers to fulfill their mission of caring for patients. Table of Contents Needles & Accessories …………………………………………….....…...3 Catheters & Accessories ……………………….………………..…...…...18 Dilation & Accessories ……………………………………………...…...25 Spinal & Accessories ……………………………………………...…...30 Implantables & Accessories……………………………………………...…...35 Needles & Accessories HYSTO SYSTEM Automatic Biopsy Instrument……………………….……….…….. 4 HYSTO SYSTEM II Automatic Biopsy Instrument…………………….……….……...5 SAMPLE MASTER Semi-Automatic Biopsy Instrument…………………………….. 6 HYSTO-ONE Automatic Reusable Biopsy Instrument & MDA Biopsy Needle ....... 7 HYSTO-TWO Automatic Reusable Biopsy Instrument & MDS Biopsy Needle…...
    [Show full text]
  • Evaluation of Nipple Discharge
    New 2016 American College of Radiology ACR Appropriateness Criteria® Evaluation of Nipple Discharge Variant 1: Physiologic nipple discharge. Female of any age. Initial imaging examination. Radiologic Procedure Rating Comments RRL* Mammography diagnostic 1 See references [2,4-7]. ☢☢ Digital breast tomosynthesis diagnostic 1 See references [2,4-7]. ☢☢ US breast 1 See references [2,4-7]. O MRI breast without and with IV contrast 1 See references [2,4-7]. O MRI breast without IV contrast 1 See references [2,4-7]. O FDG-PEM 1 See references [2,4-7]. ☢☢☢☢ Sestamibi MBI 1 See references [2,4-7]. ☢☢☢ Ductography 1 See references [2,4-7]. ☢☢ Image-guided core biopsy breast 1 See references [2,4-7]. Varies Image-guided fine needle aspiration breast 1 Varies *Relative Rating Scale: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate Radiation Level Variant 2: Pathologic nipple discharge. Male or female 40 years of age or older. Initial imaging examination. Radiologic Procedure Rating Comments RRL* See references [3,6,8,10,13,14,16,25- Mammography diagnostic 9 29,32,34,42-44,71-73]. ☢☢ See references [3,6,8,10,13,14,16,25- Digital breast tomosynthesis diagnostic 9 29,32,34,42-44,71-73]. ☢☢ US is usually complementary to mammography. It can be an alternative to mammography if the patient had a recent US breast 9 mammogram or is pregnant. See O references [3,5,10,12,13,16,25,30,31,45- 49]. MRI breast without and with IV contrast 1 See references [3,8,23,24,35,46,51-55].
    [Show full text]
  • Ultrasound, Elastography and MRI Mammography
    EAS Journal of Radiology and Imaging Technology Abbreviated Key Title: EAS J Radiol Imaging Technol ISSN 2663-1008 (Print) & ISSN: 2663-7340 (Online) Published By East African Scholars Publisher, Kenya Volume-1 | Issue-2 | Mar-Apr-2019 | Research Article Ultrasound, Elastography and MRI Mammography Correlation in Breast Pathologies (A Study of 50 Cases) Dr Hiral Parekh.1, Dr Lata Kumari.2, Dr Dharmesh Vasavada.3 1Professor, Department of Radiodiagnosis M P Shah Government Medical College Jamnagar, Gujarat, India 2Resident Doctor in Radiodiagnosis Department of Radiodiagnosis M P Shah Government Medical College Jamnagar, Gujarat, India 3Professor, Department of Surgery M P Shah Government Medical College Jamnagar, Gujarat, India *Corresponding Author Dr Dharmesh Vasavada Abstract: Introduction: The purpose of this study is to investigate the value of MRI in comparison to US and mammography in diagnosis of breast lesions. MRI is ideal for breast imaging due to its ability to depict excellent soft tissue contrast. Methods: This study of 50 cases was conducted in the department of Radiodiagnosis, Guru Gobinsingh Government Hospital, M P Shah Government Medical College, Jamnagar, Gujarat, India. All 50 cases having or suspected to have breast lesions were chosen at random among the indoor and outdoor patients referred to the Department of Radiodiagnosis for imaging. Discussion: In the present study the results of sonoelastography were compared with MRI. The malignant masses were the commonest and the mean age of patients with malignant masses in our study was 45 years, which is in consistent with Park‟s statement that the mean age of breast cancer occurrence is about 42 years in India3.
    [Show full text]
  • Diagnostic Accuracy of Shear Wave Elastography for Prediction of Breast Malignancy in Patients with Pathological Nipple Discharge
    Open Access Research BMJ Open: first published as 10.1136/bmjopen-2015-008848 on 22 January 2016. Downloaded from Diagnostic accuracy of shear wave elastography for prediction of breast malignancy in patients with pathological nipple discharge Xiaobo Guo,1 Ying Liu,1 Wanhu Li2 To cite: Guo X, Liu Y, Li W. ABSTRACT Strengths and limitations of this study Diagnostic accuracy of shear Objectives: Pathological nipple discharge (PND) may wave elastography for indicate malignant breast lesions. As the role of shear ▪ prediction of breast Diagnostic accuracy of shear wave elastography wave elastography (SWE) in predicting these malignant malignancy in patients with (SWE) for detecting malignancy of patients with pathological nipple discharge. lesions has not yet been evaluated, we aim to evaluate PND has rarely been studied. BMJ Open 2016;6:e008848. the diagnostic value of SWE for this condition. ▪ For the first time, this study tested diagnostic doi:10.1136/bmjopen-2015- Design: Prospective diagnostic accuracy study accuracy of a synthesised measurement of quali- 008848 comparing a combination of qualitative and quantitative tative and quantitative measures of SWE for measurements of SWE (index test) to a ductoscopy detecting malignancy in patients with PND. ▸ Prepublication history for and microdochectomy for histological diagnosis ▪ Limitations include the fact that the weight of this paper is available online. (reference test). each measurement in the synthesised score was To view these files please Setting: Fuzhou General Hospital of Nanjing military assigned evenly and the surgeon was not visit the journal online command. blinded. (http://dx.doi.org/10.1136/ Participants: A total of 379 patients with PND were bmjopen-2015-008848).
    [Show full text]
  • Ijcem0007780.Pdf
    Int J Clin Exp Med 2015;8(6):8506-8515 www.ijcem.com /ISSN:1940-5901/IJCEM0007780 Original Article Ultrasound elastography and magnetic resonance examinations are effective for the accurate diagnosis of mammary duct ectasia Feixue Zhang1, Dexin Yu2, Mingming Guo3, Qing Wang2, Zhigang Yu3, Fei Zhou3, Meng Zhao2, Feng Xue2, Guangrui Shao4 1Department of Radiology, Division of Ultrasound, The Second Hospital of Shandong University, Jinan City, Shan- dong Province, P.R. China; 2Department of Radiology, Qilu Hospital, Shandong University, Jinan City, Shandong Province, P.R. China; 3Department of Breast Surgery, The Second Hospital of Shandong University, Jinan City, Shandong Province, P.R. China; 4Department of Radiology, The Second Hospital of Shandong University, Jinan City, Shandong Province, P.R. China Received March 10, 2015; Accepted May 28, 2015; Epub June 15, 2015; Published June 30, 2015 Abstract: Objectives: This study is to investigate the values of multiple quantitative evaluation parameters in the diagnosis of mammary duct ectasia (MDE), using real-time ultrasound elastography (UE) and magnetic resonance imaging (MRI). Methods: This retrospective study was performed on 15 patients (16 lesions) with MDE. Ultrasound examination was performed with the LOGIQ E9 ultrasound instrument, with all lesions being examined by routine ultrasound and UE. MRI examination was performed with a Signa HD × 3.0T TWINSP MR System, including of plain- scan, diffusion-weighted imaging, dynamic contrast-enhanced MRI, and proton magnetic resonance spectroscopy. Imaging features, as well as semi-quantitative and quantitative parameters, were analyzed to determine their diag- nostic value for MDE. Results: According to the five-point scale in UE, twelve lesions belonged to 1-3 point scale, and four lesions were in 4-5 point scale, with an average of 2.93 ± 0.77.
    [Show full text]
  • Journal of Surgery Leong A, Et Al
    Journal of Surgery Leong A, et al. J Surg: JSUR-1154. Research Article DOI: 10.29011/2575-9760. 001154 Variations in Abnormal Nipple Discharge Management in Women- a Systematic Review and Meta-analysis Alison Leong, Alison Johnston, Michael Sugrue* Department of Breast Surgery, Breast Centre North West, Donegal Clinical Research Academy, Letterkenny University Hospital, Done- gal, Ireland *Corresponding author: Michael Sugrue, Department of Breast Surgery, Breast Centre North West, Donegal Clinical Research Academy, Letterkenny University Hospital, Donegal, Ireland. Tel: +353749188823; Fax: +353749188816; Email: michael.sugrue@ hse.ie Citation: Leong A, Johnston A, Sugrue M (2018) Variations in Abnormal Nipple Discharge Management in Women- a Systematic Review and Meta-analysis. J Surg: JSUR-1154. DOI: 10.29011/2575-9760. 001154 Received Date: 13 July, 2018; Accepted Date: 19 July, 2018; Published Date: 26 July, 2018 Abstract Nipple discharge accounts for 5% of referrals to breast units; breast cancer in image negative nipple discharge patients varies from 0 to 21%. This systematic review and meta-analysis determined variability in breast cancer rates in nipple discharge patients, diagnostic accuracy of modalities and surgery rates. An ethically approved meta-analysis was conducted using data- bases PubMed, EMBASE, and Cochrane Library from January 2000 to July 2015. For the breast cancer rates’ review, studies were excluded if no clinical follow-up data was available. For the diagnostic accuracy meta-analysis, studies were excluded if there was no reference standard, or the number of true and false positives and negatives were not known. Pooled sensitivities were determined using Mantel-Haenszel method. For the surgery rates’ review, only studies with consecutive nipple discharge patients were included.
    [Show full text]
  • The Automated Breast Volume Scanner (ABVS): Initial Experiences in Lesion Detection Compared with Conventional Handheld B-Mode Ultrasound: a Pilot Study of 50 Cases
    International Journal of Women’s Health Dovepress open access to scientific and medical research Open Access Full Text Article ORIGINAL RESEARCH The Automated Breast Volume Scanner (ABVS): initial experiences in lesion detection compared with conventional handheld B-mode ultrasound: a pilot study of 50 cases Sebastian Wojcinski1 Abstract: The idea of an automated whole breast ultrasound was developed three decades ago. Andre Farrokh1 We present our initial experiences with the latest technical advance in this technique, the automated 2 Ursula Hille breast volume scanner (ABVS) ACUSON S2000TM. Volume data sets were collected from 50 3 Jakub Wiskirchen patients and a database containing 23 women with no detectable lesions in conventional ultrasound Samuel Gyapong1 (BI-RADS®-US 1), 13 women with clearly benign lesions (BI-RADS®-US 2), and 14 women with Amr A Soliman1,4 known breast cancer (BI-RADS®-US 5) was created. An independent examiner evaluated the ABVS Friedrich Degenhardt1 data on a separate workstation without any prior knowledge of the patients’ histories. The diagnostic Peter Hillemanns2 accuracy for the experimental ABVS was 66.0% (95% confidence interval [CI]: 52.9–79.1). The 1 Department of OB/GYN, Franziskus independent examiner detected all breast cancers in the volume data resulting in a calculated sensi- Hospital, Bielefeld, Germany; 2Department of OB/GYN, Hannover Medical School, tivity of 100% in the described setting (95% CI: 73.2%–100%). After the ABVS examination, there 3 Hannover, Germany; Department of were a high number of requests for second-look ultrasounds in 47% (95% CI: 30.9–63.5) of the Radiology, Franziskus Hospital, Bielefeld, Germany; 4Department of OB/GYN, Faculty healthy women (with either a clearly benign lesion or no breast lesions at all in conventional handheld of Medicine, University of Alexandria, ultrasound).
    [Show full text]
  • DBT-Galactography: a Promising Tool for Improving the Diagnostic Workup
    Moschetta et al. European Radiology Experimental (2020) 4:40 European Radiology https://doi.org/10.1186/s41747-020-00170-5 Experimental ORIGINAL ARTICLE Open Access DBT-galactography: a promising tool for improving the diagnostic workup of nipple discharge Marco Moschetta1*, Vincenzo De Ruvo1, Angelica Drago2, Nicoletta Troiano2, Simona Paolicelli2, Giuseppe Rubini2, Amato Antonio Stabile Ianora2 and Michele Telegrafo1 Abstract Background: Our aim was to compare the diagnostic performance of digital breast tomosynthesis (DBT)- galactography with that of full-field digital (FFD)-galactography for detecting intraductal breast lesions using an intra-individual design. Methods: Forty-nine consecutive patients with spontaneous, unilateral, single-pore nipple discharge and inconclusive FFD mammography and ultrasonography underwent galactography with a “COMBO” technique combining FFD- and DBT-galactography acquisitions. Examinations were independently analysed by two breast radiologists with 10-year experience. Sensitivity, specificity, and accuracy for both FFD- and DBT-galactography were calculated having histological examinations of surgical specimens as a reference standard. Data were presented as percentages with their 95% confidence intervals (CI). McNemar test was used. Interobserver agreement was assessed by using Cohen κ test for both techniques. Results: Sensitivity was 41/43 (95%, 95% CI 84.2–99.4) for DBT-galactography and 33/43 (77%, 95% CI 61.4–88.2) for FFD-galactography (p = 0.008), specificity 6/6 (100%, 95% CI 54.1–100.0) for both imaging tools, accuracy 47/49 (96%, 95% CI 86.0–99.5) and 39/49 (80%, 95% CI 65.7–89.8) (p = 0.038), respectively. The inter-observer agreement was 0.86 for DBT-galactography and 0.78 for FFD-galactography.
    [Show full text]
  • Evicore Breast Imaging
    CLINICAL GUIDELINES Breast Imaging Policy Version 1.0 Effective February 14, 2020 eviCore healthcare Clinical Decision Support Tool Diagnostic Strategies: This tool addresses common symptoms and symptom complexes. Imaging requests for individuals with atypical symptoms or clinical presentations that are not specifically addressed will require physician review. Consultation with the referring physician, specialist and/or individual’s Primary Care Physician (PCP) may provide additional insight. CPT® (Current Procedural Terminology) is a registered trademark of the American Medical Association (AMA). CPT® five digit codes, nomenclature and other data are copyright 2017 American Medical Association. All Rights Reserved. No fee schedules, basic units, relative values or related listings are included in the CPT® book. AMA does not directly or indirectly practice medicine or dispense medical services. AMA assumes no liability for the data contained herein or not contained herein. © 2019 eviCore healthcare. All rights reserved. Breast Imaging Guidelines V1.0 Breast Imaging Guidelines Abbreviations for Breast Guidelines 3 BI-RADS™ Categories Chart 5 BR-1: Breast Ultrasound 7 BR-2: MRI Breast 8 BR-3: Breast Reconstruction 10 BR-4: MRI Breast is NOT Indicated 11 BR-5: MRI Breast Indications 12 BR-6: Nipple Discharge/Galactorrhea 15 BR-7: Breast Pain (Mastodynia) 16 BR-8: Alternative Breast Imaging Approaches 17 BR-9: Suspected Breast Cancer in Males 18 ______________________________________________________________________________________________________
    [Show full text]
  • CAR Breast Imaging and Intervention Guideline
    CAR PRACTICE GUIDELINES AND TECHNICAL STANDARDS FOR BREAST IMAGING AND INTERVENTION APPROVED ON SEPTEMBER 29, 2012 CHAIR, SHIELA APPAVOO, MD; ANN ALDIS, MD; PETRINA CAUSER, MD; PAVEL CRYSTAL, MD; BENOÎT MESUROLLE, MD; YOLANDA MUNDT, MRT; NEETY PANU, MD; JEAN SEELY, MD; NANCY WADDEN, MD MODIFIED ON SEPTEMBER 17, 2016: CHAIR, SHIELA APPAVOO, MD; ANN ALDIS, MD; PETRINA CAUSER, MD; PAVEL CRYSTAL, MD; ANAT KORNECKI, MD; YOLANDA MUNDT, MRT; JEAN SEELY, MD; NANCY WADDEN, MD The practice guidelines of the Canadian Association of Radiologists (CAR) are not rules, but are guidelines that attempt to define principles of practice that should generally produce radiological care. The radiologist and medical physicist may modify an existing practice guideline as determined by the individual patient and available resources. Adherence to CAR practice guidelines will not assure a successful outcome in every situation. The practice guidelines should not be deemed inclusive of all proper methods of care or exclusive of other methods of care reasonably directed to obtaining the same results. The practice guidelines are not intended to establish a legal standard of care or conduct, and deviation from a practice guideline does not, in and of itself, indicate or imply that such medical practice is below an acceptable level of care. The ultimate judgment regarding the propriety of any specific procedure or course of conduct must be made by the physician and medical physicist in light of all circumstances presented by the individual situation. Approved on September
    [Show full text]
  • Recommendations for Medical Imaging Procedures
    Recommendations for medical imaging procedures Recommendation by the German Commission on Radiological Protection Adopted at the 300th SSK meeting on 27 June 2019 For many decades, diagnostic imaging has been an indispensable tool of ensure referral guidelines modern medicine to clarify diagnostic questions, thus allowing for the for medical imaging, taking planning of appropriate individual treatments. Some examination methods into account the radiation such as X-ray or nuclear medical diagnostics involve ionising radiation or doses, are available to the radioactive substances. In view of the radiological exposure involved in referrers. such procedures, physicians must consider carefully whether a different The Federal Environment diagnostic method with less or no radiation exposure, such as ultrasound Ministry, being responsible for radiological protection, has for many years or magnetic resonance procedures, might not be at least equally well advocated keeping the number of applications involving radiation suited for a specific patient. Therefore the Recommendations for medical exposure as low as possible. There is constant enhancement of imaging procedures address first of all physicians referring patients for diagnostic procedures and therefore these recommendations are further diagnostics. The goal is to avoid unnecessary radiation exposure reviewed and updated on a regular basis. while achieving the same level of diagnostic accuracy. I would like to thank the German Commission on Radiological Protection, the The recommendations list the most suitable imaging procedures for various medical associations involved and in particular the working group under various diagnostic questions. However, physicians must still provide in the chair of Professor Reinhard Loose for their work. each individual case the justifying indication for the selected examination method and document it.
    [Show full text]